Advancing neoadjuvant immunotherapy in non-small cell lung cancer (NSCLC): commentary on the Lung Cancer Mutation Consortium 3 trial (LCMC3)

Chen, L. N., Stanifer, B. P., Sonett, J. R., & Shu, C. A. (2024). Advancing neoadjuvant immunotherapy in non-small cell lung cancer (NSCLC): commentary on the Lung Cancer Mutation Consortium 3 trial (LCMC3). AME Clinical Trials Review, 2, 37–37. https://doi.org/10.21037/actr-24-13
Authors:
Lanyi Nora Chen
B.P. Stanifer
Joshua Sonett
Catherine A. Shu
Affiliated Authors:
Lanyi Nora Chen
B.P. Stanifer
Joshua Sonett
Catherine A. Shu
Columbia Affiliation:
Subjects:
Advancements in Lung Cancer Research (OpenAlex Topic)
Cancer Immunotherapy (OpenAlex Topic)
Diagnosis and Treatment of Lung Cancer (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.21037/actr-24-13
DOI:
10.21037/actr-24-13
Journal:
AME Clinical Trials Review
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: